WASHINGTON, D.C. – Today, U.S. Senators Rand Paul (R-KY), Joe Manchin (D-WV), and Ted Budd (R-NC) sent a letter to Dr. Robert Califf, Commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA) urging the FDA Center for Tobacco Products (CTP) to reform its application review process for harm-reduced products. The Senators also requested information about CTP’s policies and actions to ensure it is acting efficiently and in a way that is based on science and evidence.

WASHINGTON, D.C. – Today, U.S. Senators Rand Paul (R-KY) and Edward J. Markey (D-MA), chair of the Health, Education, Labor and Pensions (HELP) Subcommittee on Primary Health and Retirement Security, issued the following statement after the Senate HELP Committee passed the Modernizing Opioid Treatment Access Act (MOTAA), legislation to allow board certified addiction medicine and addiction psychiatry doctors registered with the Drug Enforcement Administration (DEA) to prescribe methadone that patients could pick up at a pharmacy. The bipartisan legislation would represent the first major reform to methadone in half a century and is supported by hundreds of clinicians and medical organizations.

WASHINGTON, D.C. – Yesterday, U.S. Senator Rand Paul (R-KY) sent a letter to Dr. Robert Califf, Commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA) about the FDA’s recent proposed rule on Laboratory Developed Tests (LDTs). The proposed rule would inappropriately impose the FDA’s medical device regulatory framework on health care providers developing and performing LDTs as part of their professional practice. It would also cause unnecessary disruptions to patient care.